Correlation Between In8bio and Gain Therapeutics
Can any of the company-specific risk be diversified away by investing in both In8bio and Gain Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining In8bio and Gain Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between In8bio Inc and Gain Therapeutics, you can compare the effects of market volatilities on In8bio and Gain Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in In8bio with a short position of Gain Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of In8bio and Gain Therapeutics.
Diversification Opportunities for In8bio and Gain Therapeutics
0.06 | Correlation Coefficient |
Significant diversification
The 3 months correlation between In8bio and Gain is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding In8bio Inc and Gain Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gain Therapeutics and In8bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on In8bio Inc are associated (or correlated) with Gain Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gain Therapeutics has no effect on the direction of In8bio i.e., In8bio and Gain Therapeutics go up and down completely randomly.
Pair Corralation between In8bio and Gain Therapeutics
Given the investment horizon of 90 days In8bio Inc is expected to generate 2.21 times more return on investment than Gain Therapeutics. However, In8bio is 2.21 times more volatile than Gain Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Gain Therapeutics is currently generating about 0.01 per unit of risk. If you would invest 187.00 in In8bio Inc on November 9, 2024 and sell it today you would lose (159.00) from holding In8bio Inc or give up 85.03% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
In8bio Inc vs. Gain Therapeutics
Performance |
Timeline |
In8bio Inc |
Gain Therapeutics |
In8bio and Gain Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with In8bio and Gain Therapeutics
The main advantage of trading using opposite In8bio and Gain Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if In8bio position performs unexpectedly, Gain Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gain Therapeutics will offset losses from the drop in Gain Therapeutics' long position.In8bio vs. Reviva Pharmaceuticals Holdings | In8bio vs. Cue Biopharma | In8bio vs. Lantern Pharma | In8bio vs. Anixa Biosciences |
Gain Therapeutics vs. Biovie Inc | Gain Therapeutics vs. In8bio Inc | Gain Therapeutics vs. NewAmsterdam Pharma | Gain Therapeutics vs. Cue Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |